Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Cardiology Reports
|
August 23, 2000
Emerging indications for permanent pacing
D L Wolbrette, G V Naccarelli
Current Opinion in Cardiology
|
December 22, 2000
Management of implantable cardioverter defibrillator patients: role of predischarge electrophysiologic testing and proper patient instruction before hospital discharge
D L Wolbrette, G V Naccarelli
The Medical Clinics of North America
|
March 10, 2001
Proarrhythmia
G V Naccarelli, D L Wolbrette, J C Luck
Current Opinion in Cardiology
|
February 10, 2000
Amiodarone: clinical trials
G V Naccarelli, D L Wolbrette, H M Patel, et al.
American Family Physician
|
August 26, 1998
Drugs for conversion of atrial fibrillation
J T Dell'Orfano, J C Luck, D L Wolbrette, et al.
The American Journal of Cardiology
|
March 18, 1999
Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care
J T Dell'Orfano, H Patel, D L Wolbrette, et al.
Journal of Cardiovascular Electrophysiology
|
September 4, 1998
A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators
G V Naccarelli, D L Wolbrette, J T Dell'Orfano, et al.
Clinical Cardiology
|
February 17, 2000
Amiodarone: what have we learned from clinical trials?
G V Naccarelli, D L Wolbrette, J T Dell'Orfano, et al.
The American Journal of Cardiology
|
May 24, 2000
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy
G V Naccarelli, J T Dell'Orfano, D L Wolbrette, et al.
Journal of Internal Medicine
|
June 30, 2007
Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study
Y Hong, X Jin, J Mo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Cardiology Reports
|
August 23, 2000
Emerging indications for permanent pacing
D L Wolbrette, G V Naccarelli
Current Opinion in Cardiology
|
December 22, 2000
Management of implantable cardioverter defibrillator patients: role of predischarge electrophysiologic testing and proper patient instruction before hospital discharge
D L Wolbrette, G V Naccarelli
The Medical Clinics of North America
|
March 10, 2001
Proarrhythmia
G V Naccarelli, D L Wolbrette, J C Luck
Current Opinion in Cardiology
|
February 10, 2000
Amiodarone: clinical trials
G V Naccarelli, D L Wolbrette, H M Patel, et al.
American Family Physician
|
August 26, 1998
Drugs for conversion of atrial fibrillation
J T Dell'Orfano, J C Luck, D L Wolbrette, et al.
The American Journal of Cardiology
|
March 18, 1999
Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care
J T Dell'Orfano, H Patel, D L Wolbrette, et al.
Journal of Cardiovascular Electrophysiology
|
September 4, 1998
A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators
G V Naccarelli, D L Wolbrette, J T Dell'Orfano, et al.
Clinical Cardiology
|
February 17, 2000
Amiodarone: what have we learned from clinical trials?
G V Naccarelli, D L Wolbrette, J T Dell'Orfano, et al.
The American Journal of Cardiology
|
May 24, 2000
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy
G V Naccarelli, J T Dell'Orfano, D L Wolbrette, et al.
Journal of Internal Medicine
|
June 30, 2007
Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study
Y Hong, X Jin, J Mo, et al.
Page
of 2